Clinical Trial

Suprachoroidal Administration in Subjects With Metastases to the Choroid

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-10-14; most recent amendment 2026-03-11.
Status change: Not Yet Recruiting → Recruiting 2025-09-26
Trial Details
NCT Number NCT06643884
Lead Sponsor Aura Biosciences
Conditions Eye Cancer, Primary Cancer
Enrollment 24 participants
Start Date 2024-12-16
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-13